Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Treasury Shares: 2020-2024

  • Eton Pharmaceuticals' Treasury Shares fell 17.55% to $226,068 in Q4 2024 from the same period last year, while for Dec 2024 it was $226,068, marking a year-over-year decrease of 17.55%. This contributed to the annual value of $226,068 for FY2024, which is 17.55% down from last year.
  • Eton Pharmaceuticals' Treasury Shares amounted to $226,068 in Q4 2024, which was down 17.55% from $274,204 recorded in Q4 2023.
  • In the past 5 years, Eton Pharmaceuticals' Treasury Shares ranged from a high of $369,606 in Q3 2022 and a low of $7,595 during Q4 2020.
  • Its 3-year average for Treasury Shares is $309,871, with a median of $321,905 in 2022.
  • Data for Eton Pharmaceuticals' Treasury Shares shows a maximum YoY declined of 25.81% (in 2023) over the last 5 years.
  • Eton Pharmaceuticals' Treasury Shares (Quarterly) stood at $7,595 in 2020, then reached $369,606 in 2022, then declined by 25.81% to $274,204 in 2023, then decreased by 17.55% to $226,068 in 2024.
  • Its Treasury Shares was $226,068 in Q4 2024, compared to $274,204 in Q4 2023 and $369,606 in Q4 2022.